Vinod Matole, Parikshit Shirure, Ajay Bedadurge, Mahesh Kadare, Mahesh Thore
Vinod Matole*, Parikshit Shirure, Ajay Bedadurge, Mahesh Kadare, Mahesh Thore
Shivai Charitable Trust’s College of Pharmacy, Koregaonwadi.
Volume - 11,
Issue - 1,
Year - 2021
Except for skin, the eye is the most easily accessible site for topical administration of a medication. Drugs are commonly applied to the eye for a localized action, on the surface, or in the interior of the eye. A major problem in ocular therapeutics is the attainment of an optimal drug concentration at the site of action. Poor bioavailability of drugs from ocular dosage forms is mainly due to the pre corneal loss factors which include tear dynamics, non-productive absorption, transient residence time in the cul-de-sac (a region near to palpebral conjunctiva), and the relative impermeability of the corneal epithelial membrane.
Cite this article:
Vinod Matole, Parikshit Shirure, Ajay Bedadurge, Mahesh Kadare, Mahesh Thore. A Brief Review on Ocular Drug Delivery System. Asian J. Pharm. Res. 2021; 11(1):67-70. doi: 10.5958/2231-5691.2021.00014.9
1. Patel PB, Shastri DH. Ophthalmic drug delivery System: Challenges and Approaches. Systemic review in Pharmacy, 2010;1(2):113-120.
2. Kaur H, Kumar S. Ocular drug delivery System: A review. European J. of Pharmaceutical and Medical Research, 2019;6(12):251-261.
3. Yerikala R, Kothapali CB. A novel approach on ocular drug delivery system. J. of Drug delivery and Therapeutics, 2017;7(6):117-124.
4. Palani S, Joseph NM. Ocular Drug Delivery: A Review. Int. J. of Pharma. Sci. & Res., 2010;1(3):1-11.
5. Dhanapal R. Ocular drug delivery System- A Review. Innovation Drug Discovery, 2012;2(1):4-15.